ReviewMikrochimica acta2025
Applications of microfluidic chip technology in microvascular thrombosis research.
Review in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Circulating Bubbles in Decompression Sickness: Pathophysiology and Experimental Models.Biomolecules · 2026Review
- Microfluidics for Blood Disorders and Hematological Disease Monitoring and Modeling.International journal of molecular sciences · 2026Review
- Next Generation Experimental Models of Venous Physiology and Pathology: Examining Human Relevance in Recapitulating Lower Extremity Flow and Valve Function in New Approach Methods (NAMs).Small (Weinheim an der Bergstrasse, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The formation and progression of microvascular thrombosis are critical mechanisms underlying many vascular-related diseases. Therefore, replicating the microvascular blood flow environment in vitro and investigating the mechanisms of microvascular thrombosis formation are highly significant. In recent years, microfluidic chip technology has been extensively applied in in vitro research for its capability to systematically and comprehensively replicate the complex processes of microvascular thrombosis in laboratory settings. This review systematically examines the development and applications of microfluidic chip technology in microvascular thrombosis research. It begins with a brief summary of the technical features of microfluidic chip technology, followed by a detailed discussion of its applications in constructing in vitro microvascular models, investigating thrombosis mechanisms, and evaluating antithrombotic drug efficacy. Finally, the review summarizes the current research progress and discusses potential directions for future development. This review also systematically explains the breakthrough contribution of microfluidic chips from the perspective of engineering bionics and provides new insights for the pathological research and clinical management of microvascular thrombosis: constructing a high-precision physiological simulation system through bionic topology design and dynamic fluid regulation to achieve high-precision reconstruction of vascular dynamic microenvironment; based on the systems-level dynamics analysis, the dynamic evolution law of multi-factor synergy in the process of thrombosis is revealed; construct a drug-response evaluation system and establish a transformation bridge from micro-mechanism to clinical intervention. In summary, this review is expected to accelerate the development of targeted therapies and diagnostic tools for microvascular thrombosis.
Indexed as
Identifiers
40413353What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.